Next Generation Sequencing (NGS) Market - Global Forecast to 2023
This report studies the global next generation sequencing market over the forecast period of 2018 to 2023. The global next-generation sequencing market is estimated to grow at a CAGR of XX% from 2018 to 2023 to reach USD XX Billion by 2023. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market.
Date : 2018-07-24
Price Single User:
Price Multiple User:
OBJECTIVES OF THE STUDY
- To define, describe, and forecast the Next Generation Sequencing (NGS) market in different segmentations
- To forecast the market size in terms of value for various segments with respect to four main regions: North America, Europe, APAC, and RoW
- To provide detailed information regarding the major factors influencing the growth of the Next Generation Sequencing (NGS) market (drivers, restraints, opportunities, and industry-specific challenges)
- To provide a detailed overview of the value chain in the Next Generation Sequencing (NGS) market and analyze the market trends with Porter’s five forces analysis
- To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Next Generation Sequencing (NGS) market
- To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
- To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Next Generation Sequencing (NGS) market
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Next-Generation Sequencing (NGS): Market Overview
4.2 Next-Generation Sequencing Market, By Product & Service
4.3 Next-Generation Sequencing Market Size, By Application
4.4 Next-Generation Sequencing Market, By End User
4.5 Geographic Analysis: Next-Generation Sequencing Market Size, By Product & Service
5 Next-Generation Sequencing Market Overview
5.2 Next-Generation Sequencing Market Dynamics
5.2.5 Industry Trends
6 Next-Generation Sequencing Market, By Product & Service
6.2 Pre-Sequencing Products & Services Market
6.2.1 Sample Preparation
6.3 NGS Platforms, Consumables, & Services for Platforms
6.3.1 NGS Platforms Market
6.4 Sequencing Services Market
6.4.1 Targeted Re-Sequencing
6.4.3 De Novo Sequencing
6.4.4 Exome Sequencing
6.4.6 Whole-Genome Sequencing
6.4.8 Other Applications
6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
6.5.1 NGS Data Analysis Software & Workbenches
6.5.2 NGS Data Analysis Services
6.5.3 NGS Storage, Management, and Cloud Computing Solutions
7 Next-Generation Sequencing Market, By Technology
7.2 Sequencing By Synthesis
7.3 ION Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing
8 Next-Generation Sequencing Market, By Application
8.3 Drug Discovery
8.4 Biomarker Discovery
8.5 Precision Medicine
8.6 Agriculture & Animal Research
8.7 Other Applications
9 Next-Generation Sequencing Market, By End User
9.2 Research Centers and Academic & Government Institutes
9.3 Hospitals & Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users
10 Next-Generation Sequencing Market, By Region
10.2 North America
10.5 Rest of the World (RoW)
11 Competitive Landscape
11.2 Next-Generation Sequencing Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches, Product Enhancements, and Service Launches
11.3.2 Agreements, Partnerships, Collaborations, and Contracts
11.3.3 Mergers and Acquisitions
11.3.5 Other Developments
12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.2 Illumina, Inc.
12.3 Thermo Fisher Scientific Inc.
12.4 Pacific Biosciences of California, Inc.
12.5 Qiagen N.V.
12.6 Beijing Genomics Institute
12.7 Perkinelmer, Inc.
12.8 F. Hoffmann-La Roche AG
12.9 Agilent Technologies, Inc.
12.10 Gatc Biotech AG
12.11 Oxford Nanopore Technologies, Ltd.
12.12 Macrogen, Inc.
12.13 Eurofins Scientific
*Details on Delving Market Research View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
On the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2018, the consumables segment is expected to account for the largest share of the market. The pre-sequencing products and services segment is expected to register the highest CAGR during the forecast period primarily due to the growing need for standardized sample preparation solutions and increasing automation in pre-sequencing.
Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing & developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases.
On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2018, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina’s systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.
On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Geographically, the NGS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2018, followed by Europe. The market in North America is primarily driven by the technological advancements, availability of commercial solutions for NGS data analysis, and the strong presence of key players in this region. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2018 to 2023, due to the improving healthcare infrastructure and favorable government initiatives in this region.
The major players in the global next-generation sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N. V. (Germany), Pacific Biosciences of California, Inc. (U.S.), BGI (China), Oxford Nanopore Technologies, Ltd. (U.K.), PerkinElmer, Inc. (U.S.), GATC Biotech AG (Germany), Agilent Technologies, Inc. (U.S.), Roche Holding AG (Switzerland), Macrogen, Inc. (South Korea), and Eurofins Scientific (Luxembourg).